US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Action Energy Inc (EM) (AECFF) 銘柄情報

Action Energy Inc (EM) (AECFF)

0.000001

0.00

(0.00%)

終了 6月16日 5:00AM

Action Energy Inc (EM) (AECFF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.000001

( - )

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.000001

時価総額

前日終値

0.000001

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 271,364

発行済株式数

57,256,792

配当利回り

PER

-0

1 株当たり利益 (EPS)

-0.2

歳入

20.26M

純利益

-11.68M

Action Energy Inc. is an oil and gas exploration and development company. The company was incorporated in 1987 and is based in North Saanich, Canada. Action Energy Inc. is an oil and gas exploration and development company. The company was incorporated in 1987 and is based in North Saanich, Canada.

セクター

Energy

業界

Fossil Fuels

本社

North Saanich, Canada

設立

1987

Action Energy Inc (EM) is listed in the Energy sector of the その他OTC with ticker AECFF. The last closing price for Action Energy (EM) was US$0. Over the last year, Action Energy (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.000001.

Action Energy (EM) currently has 57,256,792 shares in issue. The market capitalisation of Action Energy (EM) is US$57.26 . Action Energy (EM) has a price to earnings ratio (PE ratio) of -0.00.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	1.0E-6	1.0E-6	1.0E-6	271364	1.0E-6	CS
12	0	0	1.0E-6	1.0E-6	1.0E-6	67841	1.0E-6	CS
26	0	0	1.0E-6	1.0E-6	1.0E-6	38766	1.0E-6	CS
52	0	0	1.0E-6	1.0E-6	1.0E-6	14282	1.0E-6	CS
156	0	0	1.0E-6	0.0001	1.0E-6	8167	3.55E-6	CS
260	-0.002499	-99.96	0.0025	0.0158	1.0E-6	5193	0.00058181	CS

AECFF - Frequently Asked Questions (FAQ)

What is the current Action Energy Inc (EM) share price?

The current share price of Action Energy Inc (EM) is US$ 0.000001

How many Action Energy Inc (EM) shares are in issue?

Action Energy Inc (EM) has 57,256,792 shares in issue

What is the market cap of Action Energy Inc (EM)?

The market capitalisation of Action Energy Inc (EM) is USD 57.26

What is the 1 year trading range for Action Energy Inc (EM) share price?

Action Energy Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.000001 during the past year

What is the PE ratio of Action Energy Inc (EM)?

The price to earnings ratio of Action Energy Inc (EM) is -0

What is the cash to sales ratio of Action Energy Inc (EM)?

The cash to sales ratio of Action Energy Inc (EM) is 0

What is the registered address of Action Energy Inc (EM)?

The registered address for Action Energy Inc (EM) is 436 Lands End Road, North Saanich, British Columbia, V8L 5L9

Which industry sector does Action Energy Inc (EM) operate in?

Action Energy Inc (EM) operates in the Fossil Fuels sector

CelestialSage6

CelestialSage6 13分前

Yes, I understand. Even if you combine all of that, can it beat Dupixent? Alteogen only collaborates with the best companies. On the other hand, Halozyme has signed contracts with companies that I don't even know if they are actually working with. So, it's not Alteogen signing with junk, but Halozym

CA Market News

CA Market News 13分前

Herbal Dispatch Provides Update on Domestic Retail Operations and Proprietary Brand ExpansionJune 16, 2026 3:01 AM
NewsfileVancouver, B

tkg

The Strategic Verdict

This Forbes article is a massive structural validation for long-term Lightwave shareholders. For years, the bears argued that Lightwave was a standalone science project trying to force its way into the market.

Now, the U.S. government and GlobalFou

Hellie

Hellie 22分前

11/06 , maybe you're right!

biotechinvestor1

biotechinvestor1 24分前

Here are a few of those drugs:
Ebglyss (IL-13)Adbry (IL-13)Nemluvio (IL-31 receptor)Late-stage agents such as zumilokibart.

Henk van vleuten

Henk van vleuten 25分前

When was it publiced? Maybe this why on 12june there was a huge spike on Jan 2027 15 options??

biotechinvestor1

biotechinvestor1 27分前

You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:

God Bless America

God Bless America 28分前

Of course they did not buy because they knew the regulation. Their families did buy instead.

US Market News

US Market News 28分前

Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2026June 16, 2026 3:00 AM
PR Newswire (US) class="legendSpanClass"BEIJING, class="legendSpanClass"June 16, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company

US Market News

US Market News 28分前

DXC Expands Relationship with Norske Skog to Modernize Network and Technology OperationsJune 16, 2026 3:00 AM
PR Newswire (US) Multi-year partnership delivers a modern, secure network solution while broadening DXC's role across Norske Sko

US Market News

US Market News 28分前

Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and InfrastructureJune 16, 2026 3:00 AM
PR Newswire (US) The company's revolutionary, pate

US Market News

US Market News 28分前

Elite Tech, Accessible Price - Introducing the Logitech G3 Series Mouse and Keyboard for PC GamingJune 16, 2026 3:05 AM
Business Wire Elite Precision - Unleash pro-grade speed with the G305 X SUPERLIGHT gaming mouse and G316 X 98 gaming keyboard. Featur

biotechinvestor1

biotechinvestor1 31分前

You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:
Late-stage agents such as zumilokibar

US Market News

US Market News 43分前

Unilever Scales Digital Twins Across Global Manufacturing Network with AccentureJune 16, 2026 2:59 AM
Business WireUnilever (LON: ULVR) is partnering with Accenture (NYSE: ACN) to scale the use of AI-enabled digital twins across its global manufacturing network

CelestialSage6

CelestialSage6 46分前

You can't refute it. Yes, I understand your level well.

biotechinvestor1

biotechinvestor1 52分前

Total nonsense! I have no interest in educating you.

Nemesis18

Nemesis18 52分前

She'll probably move to somewhere without any extradition treaty once the plug is finally pulled on this 'cancer vaccine' scam.?

price_and_volume

price_and_volume 55分前

Gonna have to bump the A/S then...
He said recently that they are looking at another acquisition...and he will dilute with shares to get it. Agreed - I posted the same, "where's the finance coming from for acquisitions?"...

Supposed 400MM shares going to $GTVH (believe it when

StockItOut

StockItOut 56分前

WKSP Weekly chart: https://schrts.co/IIIuZpgy

CelestialSage6

CelestialSage6 57分前

I understand that Halozyme has not signed any exclusive agreements regarding treatments or indications related to Dupixent, so why is Sanofi collaborating with Alteogen?

Also, Halozyme's mdase patent is being invalidated due to Merck. Alteogen's technology is more advanced than Halozy

Wolf-man jack

Wolf-man jack 58分前

WQLF SAYS: Have Mercy WQLF ahoooooo

Q: Why hasn't CV SCIENCES been accepted in the CMS Medicare Pilot Program?

Ai Generated:

C V Sciences has not been "accepted" into the CMS Medicare Pilot Program because the pilot is a provider-led incentive, not a

price_and_volume

price_and_volume 60分前

What reasonable expectation is there of PPS responding?
whether management can successfully execute on the vision they have laid out. Nobody cares about "the company" or "the management" or "their vision" or your two-bit-MBA-tutorials-in-a-post.

Enough of all that garbage.

mrwrn2010

mrwrn2010 1時間前

Disagree. The outcome of OxyContin litigation was unknown 9 months to a year ago. You can guess at a variety of outcomes, sure, but it’s not certain. Same thing with human trials - we don’t have positive trial results for anything in the pipeline until we have them. What passes in vitro may not pass

PEACHMAN

PEACHMAN 1時間前

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177680761

IFUS STRONG

Action Energy (EM)

Global Star Acquisition

3750% until 07/04/2035

Shanghai Electric (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。